Insiders I-Mab BOERSE MUENCHEN

Equities

Market Closed - BOERSE MUENCHEN Other stock markets 20:43:52 28/06/2024 BST			5-day change	1st Jan Change
1.57 ^EUR	-0.63%		-1.26%	-5.99%

06-06	I-Mab Appoints Phillip Dennis as Chief Medical Officer	CI
06-05	I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers	MT

I-Mab Appoints Phillip Dennis as Chief Medical Officer	06-06	CI
Verastem Names John Hayslip as Chief Medical Officer	04-18	MT
I-Mab Announces Chief Medical Officer Changes	04-15	CI
I-Mab Announces Executive Resignation	04-01	CI
I-Mab Announces Board Changes , Effective February 10, 2024	02-07	CI
I-Mab Names Raj Kannan CEO	22/06/23	MT
I-Mab Announces CEO Changes	22/06/23	CI
I-Mab Announces the Appointment of Raj Kannan as Member of the Board of Directors	22/06/23	CI
I-Mab Announces Board and Management Changes	03/04/23	CI
I-Mab Announces Management Changes	30/09/22	CI
I-Mab Announces Management Changes	30/08/22	CI
I-Mab Announces Executive Appointments	28/04/22	CI
I-Mab Announces Andrew Zhu Joins as President and Board Director	20/12/21	CI
I-Mab Announces Executive Changes	20/12/21	CI
I-Mab Announces Board Changes, Effective December 10, 2021	10/12/21	CI
I-Mab Names John Long CFO	01/11/21	MT
I-Mab Appoints Jielun Zhu as Chief Strategy Officer	01/11/21	CI
I-Mab Announces Committee Appointments	20/08/21	CI
I-Mab Appoints Andrew Zhu to Its Scientific Advisory Board	21/06/21	CI
I-Mab Announces Executive Appointments	01/06/21	CI

No results for this search